GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Effective Interest Rate on Debt %

NKGen Biotech (NKGen Biotech) Effective Interest Rate on Debt % : 20.30% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. NKGen Biotech's annualized positive value of Interest Expense for the quarter that ended in Mar. 2024 was $4.28 Mil. NKGen Biotech's average total debt for the quarter that ended in Mar. 2024 was $21.07 Mil. Therefore, NKGen Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 was 20.30%.

NKGen Biotech Effective Interest Rate on Debt % Historical Data

The historical data trend for NKGen Biotech's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Effective Interest Rate on Debt % Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
2.53 7.21 4.66

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Effective Interest Rate on Debt % Get a 7-Day Free Trial 20.48 1.13 4.21 8.77 20.30

Competitive Comparison of NKGen Biotech's Effective Interest Rate on Debt %

For the Biotechnology subindustry, NKGen Biotech's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NKGen Biotech's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's Effective Interest Rate on Debt % falls into.


NKGen Biotech Effective Interest Rate on Debt % Calculation

NKGen Biotech's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -0.745/( (12.034+19.921)/ 2 )
=-1  *  -0.745/15.9775
=4.66 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 12.034
=12.034

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=9.93 + 9.991
=19.921

NKGen Biotech's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2023 )+Total Debt  (Q: Mar. 2024 ))/ count )
=-1  *  -4.276/( (19.921+22.214)/ 2 )
=-1  *  -4.276/21.0675
=20.30 %

where

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=9.93 + 9.991
=19.921

Total Debt  (Q: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=10.495 + 11.719
=22.214

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

NKGen Biotech  (NAS:NKGN) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

NKGen Biotech Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Effective Interest Rate on Debt %
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.